The therapeutic potential of immunoengineering for systemic autoimmunity

Area of Science:

• Biomedical Engineering
• Immunology
• Rheumatology

Background:

• Current disease-modifying drugs have advanced systemic autoimmune disease treatment.
• Individual variations in disease mechanisms necessitate personalized therapeutic strategies.
• Emerging research focuses on patient-tailored immunophenotypic regulation.

Purpose of the Study:

• To explore the potential of immunoengineering for developing personalized therapies in rheumatic diseases.
• To highlight the role of material chemistry in designing immunomodulatory technologies.
• To discuss the application of immunoengineering in re-balancing immune responses and mitigating pathogenic inflammation.

Main Methods:

• Application of engineering principles to modulate the immune system.
• Harnessing material chemistries to design technologies for immune response modulation.
• Developing materials with properties for targeted delivery and immune function mimicry.

Main Results:

• Immunoengineering enables the design of technologies that can enhance or suppress immune responses.
• Engineered materials can localize to immune cells and organs for sustained drug delivery.
• These materials can mimic lymphoid tissue functions to restore immune balance.

Conclusions:

• Immunoengineering holds significant potential for personalized and immunoregulatory therapies in rheumatology.
• This field can improve disease modification by addressing specific immune abnormalities.
• Further development of immunoengineering applications could revolutionize rheumatic disease management.